No Data
Attention Biotech Investors - Stocks To Watch
At the RBC Global Healthcare Conference, held on 14-15 May, RBC's Healthcare Desk Sector Strategist gauged biotech investor sentiment in an interview with Biotech TV.The strategist, Chris McCarthy, sa
Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress
– Data from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia to be Presented in Plenary Session – – Additional Presentations to Highlight Quality of Life Data from ENERGIZE and Design of the
Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024
CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announc
Earnings Beat: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Agios Pharmaceuticals Is Maintained at Neutral by Goldman Sachs
Agios Pharmaceuticals Is Maintained at Neutral by Goldman Sachs
Express News | Goldman Sachs Maintains Neutral on Agios Pharmaceuticals, Raises Price Target to $33
Jimmy1819 : have you been investing professionally or as a hobby?